University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Wisconsin Madison - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5155
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, business, engineering, graduate school, law school, nursing, veterinary medicine, public affairs, medicine and public health and library and information studies, among others. It also organizes youth programs such as Badger summer sports camps, PEOPLE Program, Saturday Enrichment, and Summer Science Institute. The institution’s research centers include Agribusiness Institute, Antarctic Meteorological Research Center, Aquatic Sciences Center, Biotechnology Center, Cardiovascular Research Center and Environmental Remote Sensing Center, among others. UW-Madison is headquartered in Madison, Wisconsin, the US.

University of Wisconsin Madison – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
FluGen Raises USD12 Million in Series A Financing 13
Madison Vaccines Raises Additional USD2 Million in Series A Financing 14
Madison Vaccines Raises US$8 Million In Series A Financing 15
Partnerships 17
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Expands into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
Licensing Agreements 22
Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26
Equity Offering 27
Co-D Therapeutics Spin Off from University of Wisconsin Madison 27
University of Wisconsin Madison – Key Competitors 28
University of Wisconsin Madison – Key Employees 29
University of Wisconsin Madison – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Government and Public Interest 31
Jul 30, 2018: Researchers trace Parkinson’s damage in the heart 31
Jul 02, 2018: Study: Zika could cause more miscarriages than we realize 33
Jul 02, 2018: Zika may cause many more miscarriages than previously recognized 34
Jun 18, 2018: Researchers Uncover New Target to Stop Cancer Growth 35
May 08, 2018: Metastasis enablers: Findings could unlock new ovarian cancer treatments 36
Apr 24, 2018: Bacteria boost antifungal drug resistance in severe childhood tooth decay 38
Jan 23, 2018: Damon Runyon Cancer Research Foundation awards $3M to eleven innovative early career scientists 40
Jan 16, 2018: Study advances gene therapy for glaucoma 43
Oct 23, 2017: New study shows how cells can be led down non-cancer path 45
Aug 10, 2017: New measure of insulin-making cells could gauge diabetes progression, treatment 46
Jul 14, 2017: Advance furthers stem cells for use in drug discovery, cell therapy 47
Jun 27, 2017: Morgridge scientists illuminate structures vital to virus replication 48
Product News 50
Jan 24, 2017: Watching gene editing at work to develop precision therapies 50
Other Significant Developments 51
Jun 27, 2018: LGR6+ Cells And Defensin Peptides Deliver A New, Targeted Avenue For Treating Skin Aging 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Key Facts 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
FluGen Raises USD12 Million in Series A Financing 13
Madison Vaccines Raises Additional USD2 Million in Series A Financing 14
Madison Vaccines Raises US$8 Million In Series A Financing 15
Revive Therapeutics Enters into Research Agreement with University of Wisconsin Madison 17
NanoViricides Expands into Agreement with University of Wisconsin-Madison 18
Janssen Pharma Enters into Agreement with University of Wisconsin-Madison 19
Morphotek Enters into Research Agreement with University of Wisconsin Madison 20
UW Institute for Clinical and Translational Research to Form Partnership with German Center for Neurodegenerative Diseases 21
Cellectar Biosciences Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 22
AhR Pharma Enters Into Licensing Agreement With WARF For Cancer Fighting Hormone 23
Cellular Dynamics International Enters into Licensing Agreement with Wisconsin Alumni Research Foundation 24
AllCells Enters Into Licensing Agreement With Wisconsin Alumni Research Foundation And WiCell Research Institute 26
Co-D Therapeutics Spin Off from University of Wisconsin Madison 27
University of Wisconsin Madison, Key Competitors 28
University of Wisconsin Madison, Key Employees 29
University of Wisconsin Madison, Subsidiaries 30

List of Figures
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Wisconsin Madison, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Wisconsin Madison, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[University of Wisconsin Madison:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Giner Inc:企業の製品パイプライン分析2018
    Summary Giner Inc (Giner) is a developer of proton exchange membranes and electrochemisty products. The company offers products such as electrolyzer stacks and systems. Its solutions include membrane characterization, dimensionally stable membrane, water quality sensors, trace gas sensors, ozone gen …
  • YaSheng Group Ltd (HERB):企業の財務・戦略的SWOT分析
    Summary YaSheng Group Ltd (YaSheng) is a manufacturer of agriculture and package based products. The company operates through livestock, agriculture and biotechnology segments. YaSheng cultivates, processes, markets and distributes various food and agro-by products including field crops, fruits, veg …
  • Tomra Systems ASA (TOM):企業の財務・戦略的SWOT分析
    Summary Tomra Systems ASA (Tomra Systems) is a logistics company that offers collection and sorting solutions. The company offers products such as managing tools, process analytics equipment, food processing lines, sorting systems, raw materials, raw material sorting equipment, and other specialty p …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Anthem Inc (ANTM):企業の財務・戦略的SWOT分析
    Anthem Inc (ANTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Roswell Park Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary Roswell Park Cancer Institute (RPCI) is a cancer treatment institute that provides diagnosis, treatments and services for various kinds of cancer. The institute’s treatment includes advanced endoscopy, BMT, interventional pulmonology, interventional radiology, anesthesiologists, psychologist …
  • Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報
    Summary Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, …
  • AGL Energy Ltd (AGL)-エネルギー分野:企業M&A・提携分析
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報
    Summary InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such a …
  • Hanesbrands Inc (HBI):企業の財務・戦略的SWOT分析
    Hanesbrands Inc (HBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Inchcape plc:企業の戦略・SWOT・財務分析
    Inchcape plc - Strategy, SWOT and Corporate Finance Report Summary Inchcape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Imagion Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Imagion Biosystems Inc (Imagion Biosystems), formerly Senior Scientific LLC, a subsidiary of Manhattan Scientifics Inc, is a biomedical equipment provider that offers nanomagnetic particle detection systems. The company offers nanomagnetic relaxometry method for cancer detection and precisio …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • Zeta Petroleum Plc (ZTA):企業の財務・戦略的SWOT分析
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Zeta’s …
  • Asia Hotel Public Company Limited:企業の戦略・SWOT・財務情報
    Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Whole Foods Market Inc:戦略・SWOT・企業財務分析
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BerGenBio ASA (BGBIO)-製薬・医療分野:企業M&A・提携分析
    Summary BerGenBio ASA (BerGenBio) is a developer of drugs for aggressive and drug resistant cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 finds application in the treatment of drug resistant chronic myeloid l …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆